Westlake Ventures Capital
585 Broadway St, Redwood City, CA, 94063, United States
Overview
Their focus is investing in early stage technology startups while introducing Chinese resources and markets to American entrepreneurs and companies. Making co-investments with other funds, their company mainly invests in the technology sector, such as biotech, healthcare, loT, blockchain, enterprise software, robotics, cyber security, and VR/AR. Unique to their firm is Cross-border Technology Investment Consortium, or CTIC. This newly established investment platform specializes in bridging US startups with Chinese capital, industries, and markets by providing professional assistance in necessary paperwork required for landing. Also provided are in-house resources of over 100 investment firms and Chinese leading public companies, deep market adaption strategies, and other services. So far, they have already helped 80 US startups land in China to start a new chapter in their businesses. They welcome all, so please contact us if you have any comments, questions, or concerns.
- Total investments
- 2
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 3
Investment portfolio
- Lion TCR
Participated · Series A · May 2018
Lion TCR is a clinical-stage biotech developing engineered T-cell immunotherapy against viral-related cancers and chronic hepatitis B. Its lead candidate, LioCyx™, is a personalized HBV-specific TCR T-cell therapy targeting hepatocellular carcinoma (HCC). The company intends to use the Series A proceeds to advance ongoing clinical trials of LioCyx™ in major hospitals in China and Singapore. It also plans to broaden its product pipeline to address other viral-related solid tumours and to pursue clearance of chronic hepatitis B. Lion TCR operates manufacturing and clinical trial operations in China and Singapore and licenses engineered T-cell technologies from A*STAR (Prof. Antonio Bertoletti’s lab) and the Technical University of Munich (Prof. Urlike Protzer’s lab). The company is led by founder and CEO Dr. Victor Li and scientific founder Prof. Antonio Bertoletti.
- Manifold Technology
Participated · Series A · May 2018
Manifold built a distributed ledger platform on top of Amazon Lambda to provide serverless, scalable blockchain infrastructure. Founded by Chris Finan and Robert Seger in 2014, the team draws on intelligence and cybersecurity backgrounds (DARPA, NSA, White House, Morta Security). When enterprise adoption lagged, Manifold pivoted to consumer applications and launched Volley, a blockchain-backed augmented-reality marketplace currently in beta on the Apple App Store using ARKit. Volley includes a decentralized reputation system intended to make fake accounts expensive and improve trust and safety for buyers and sellers. The company plans an Android version in the future and views Volley both as a consumer product and a way to prove its serverless blockchain for potential enterprise reuse. Manifold raised a $7 million Series A to support this consumer direction.